Silence Therapeutics plc (SLN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 287.17M |
| Enterprise Value | 276.05M |
| P/E Ratio | -6.06 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 1,020.35 |
| Price/Book Ratio | 16.29 |
| Enterprise/Revenue | 902.87 |
| Enterprise/EBITDA | -9.2 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -97.56 |
| Operating Margin | -110.03 |
| Return On Assets | -0.56 |
| Return On Equity | -1.07 |
| Revenue | 559,000 |
| Revenue/Share | 0.01 |
| Gross Profit | 344,000 |
| EBITDA | -88.05M |
| Net Income | -88.61M |
| Diluted EPS | -1.89 |
| Total Cash | 72.05M |
| Total Cash/Share | 1.53 |
| Total Debt | -112,000 |
| Total Debt/Equity | -0 |
| Current Ratio | 7.42 |
| Book Value Per Share | 0.81 |
| 52-Week Change | 148.04 |
| 52-Week High | 17.58 |
| 52-Week Low | 4.19 |
| Moving Average 50 Days | 10.61 |
| Moving Average 200 Days | 7.28 |
| Average Volume | 940,575 |
| Shares Outstanding | 47.23M |
| % Held by Institutions | 42.15 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |